Cabio Biotech (Wuhan) Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE100005X31
CNY
19.25
-6.99 (-26.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 13.78% and Operating profit at 9.56% over the last 5 years

  • INTEREST(HY) At CNY 0.24 MM has Grown at 7.04%
  • INTEREST COVERAGE RATIO(Q) Lowest at 27,898.96
  • CASH AND EQV(HY) Lowest at CNY 361.15 MM
2

With ROE of 10.11%, it has a fair valuation with a 2.67 Price to Book Value

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

CNY 3,994 Million (Small Cap)

stock-summary
P/E

26.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.85%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

10.45%

stock-summary
Price to Book

2.45

Revenue and Profits:
Net Sales:
121 Million
(Quarterly Results - Sep 2025)
Net Profit:
21 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-24.8%
0%
-24.8%
6 Months
-10.09%
0%
-10.09%
1 Year
37.8%
0%
37.8%
2 Years
-0.7%
0%
-0.7%
3 Years
-16.64%
0%
-16.64%
4 Years
-38.39%
0%
-38.39%
5 Years
-41.32%
0%
-41.32%

Cabio Biotech (Wuhan) Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
13.78%
EBIT Growth (5y)
9.56%
EBIT to Interest (avg)
86.76
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.33
Tax Ratio
13.92%
Dividend Payout Ratio
27.15%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.13%
ROE (avg)
7.71%

Valuation key factors

Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.67
EV to EBIT
26.02
EV to EBITDA
18.87
EV to Capital Employed
2.91
EV to Sales
6.93
PEG Ratio
0.72
Dividend Yield
0.78%
ROCE (Latest)
11.17%
ROE (Latest)
10.11%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -19.56% vs -3.33% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -66.94% vs 39.64% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "121.30",
          "val2": "150.80",
          "chgp": "-19.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.30",
          "val2": "79.60",
          "chgp": "-71.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.60",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "0.10",
          "chgp": "-500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "20.50",
          "val2": "62.00",
          "chgp": "-66.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "183.90%",
          "val2": "427.50%",
          "chgp": "-24.36%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 25.64% vs 2.30% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 39.00% vs 40.26% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "553.70",
          "val2": "440.70",
          "chgp": "25.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "161.50",
          "val2": "118.40",
          "chgp": "36.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.80",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "-2.60",
          "chgp": "111.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "120.10",
          "val2": "86.40",
          "chgp": "39.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "186.10%",
          "val2": "155.00%",
          "chgp": "3.11%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
121.30
150.80
-19.56%
Operating Profit (PBDIT) excl Other Income
22.30
79.60
-71.98%
Interest
0.40
0.60
-33.33%
Exceptional Items
-0.40
0.10
-500.00%
Consolidate Net Profit
20.50
62.00
-66.94%
Operating Profit Margin (Excl OI)
183.90%
427.50%
-24.36%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is -19.56% vs -3.33% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -66.94% vs 39.64% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
553.70
440.70
25.64%
Operating Profit (PBDIT) excl Other Income
161.50
118.40
36.40%
Interest
0.60
0.80
-25.00%
Exceptional Items
0.30
-2.60
111.54%
Consolidate Net Profit
120.10
86.40
39.00%
Operating Profit Margin (Excl OI)
186.10%
155.00%
3.11%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 25.64% vs 2.30% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 39.00% vs 40.26% in Dec 2023

stock-summaryCompany CV
About Cabio Biotech (Wuhan) Co., Ltd. stock-summary
stock-summary
Cabio Biotech (Wuhan) Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available